Castle Biosciences Stock Alpha and Beta Analysis
| CSTL Stock | USD 20.52 0.45 2.24% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Castle Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Castle Biosciences over a specified time horizon. Remember, high Castle Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Castle Biosciences' market risk premium analysis include:
Beta 0.24 | Alpha (0.44) | Risk 3.82 | Sharpe Ratio (0.11) | Expected Return (0.40) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Castle |
Castle Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Castle Biosciences market risk premium is the additional return an investor will receive from holding Castle Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Castle Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Castle Biosciences' performance over market.| α | -0.44 | β | 0.24 |
Castle Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Castle Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Castle Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Castle Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Castle Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Castle Biosciences shares will generate the highest return on investment. By understating and applying Castle Biosciences stock market price indicators, traders can identify Castle Biosciences position entry and exit signals to maximize returns.
Castle Biosciences Return and Market Media
The median price of Castle Biosciences for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 is 26.66 with a coefficient of variation of 13.14. The daily time series for the period is distributed with a sample standard deviation of 3.37, arithmetic mean of 25.65, and mean deviation of 2.69. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 2230 shares by Tobin Juvenal of Castle Biosciences at 30.0 subject to Rule 16b-3 | 01/06/2025 |
2 | Castle Biosciences, Inc. Insider Derek J. Maetzold Sells 986 Shares | 01/16/2025 |
3 | CMRX Stock Skyrockets in 3 Months Heres What You Should Know | 01/31/2025 |
4 | Disposition of 8046 shares by Frank Stokes of Castle Biosciences at 26.7 subject to Rule 16b-3 | 02/20/2025 |
5 | CSTL Gears Up to Report Q4 Earnings Heres What You Should Know | 02/24/2025 |
6 | What To Expect From Castle Biosciences Inc Q4 2024 Earnings | 02/26/2025 |
7 | Castle Biosciences, Inc. Q4 2024 Earnings Call Transcript | 02/28/2025 |
8 | Disposition of 12186 shares by Frank Stokes of Castle Biosciences subject to Rule 16b-3 | 03/04/2025 |
9 | Solid Earnings Reflect Castle Biosciences Strength As A Business | 03/06/2025 |
10 | New Data to be Presented at the 2025 American Academy of Dermatology Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Bioscie... | 03/07/2025 |
11 | Disposition of 2130 shares by Derek Maetzold of Castle Biosciences at 19.518 subject to Rule 16b-3 | 03/10/2025 |
12 | Insider Selling Castle Biosciences, Inc. Insider Sells 22,6 Shares of Stock | 03/12/2025 |
13 | CSTL Gears Up to Report Q4 Earnings Heres What You Should Know - MSN | 03/21/2025 |
About Castle Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Castle or other stocks. Alpha measures the amount that position in Castle Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | |
| Payables Turnover | 6.77 | 4.38 | 3.94 | 3.88 |
| Days Of Inventory On Hand | 45.38 | 64.44 | 58.0 | 44.02 |
Castle Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Castle Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Castle Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Castle Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Castle Biosciences. Please utilize our Beneish M Score to check the likelihood of Castle Biosciences' management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Castle Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Castle Biosciences Backtesting, Castle Biosciences Valuation, Castle Biosciences Correlation, Castle Biosciences Hype Analysis, Castle Biosciences Volatility, Castle Biosciences History and analyze Castle Biosciences Performance. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Castle Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.